Publication:
Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels

dc.contributor.authorAsasutjarit R.
dc.contributor.authorThanasanchokpibull S.
dc.contributor.authorFuongfuchat A.
dc.contributor.authorVeeranondha S.
dc.date.accessioned2021-04-05T03:35:14Z
dc.date.available2021-04-05T03:35:14Z
dc.date.issued2011
dc.date.issuedBE2554
dc.description.abstractThis work was conducted to optimize and evaluate Pluronic F127-based thermoresponsive diclofenac sodium ophthalmic in situ gels (DS in situ gel). They were prepared by cold method and investigated their physicochemical properties i.e., pH, flow ability, sol-gel transition temperature, gelling capacity and rheological properties. An optimized formulation was selected and investigated its physicochemical properties before and after autoclaving, eye irritation potency in SIRC cells and rabbits. In vivo ophthalmic absorption was performed in rabbits. It was found that physicochemical properties of DS in situ gels were affected by formulation compositions. Increment of Pluronic F127 content decreased sol-gel transition temperature of the products while increase in Pluronic F68 concentration tended to increase sol-gel transition temperature. In this study, Carbopol 940 did not affect sol-gel transition temperature but it affected transparency, pH, and gelling capacity of the products. The optimized formulation exhibited sol-gel transition at 32.6 ± 1.1°C with pseudoplastic flow behavior. It was lost diclofenac sodium content during autoclaving. However, it was accepted as safe for ophthalmic use and could increase diclofenac sodium bioavailability in aqueous humor significantly. In conclusion, the optimized DS in situ gel had potential for using as an alternative to the conventional diclofenac sodium eye drop. However, autoclaving was not a suitable sterilization method for this product. © 2011 Elsevier B.V. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationInternational Journal of Pharmaceutics. Vol 411, (2011), p.128-135
dc.identifier.doi10.1016/j.ijpharm.2011.03.054
dc.identifier.issn3785173
dc.identifier.other2-s2.0-79955964137
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7304
dc.rights.holderScopus
dc.subject.otherBenzalkonium chloride
dc.subject.otherCarbopol 940
dc.subject.otherDiclofenac
dc.subject.otherPoloxamer
dc.subject.otherAnimal cell
dc.subject.otherAnimal experiment
dc.subject.otherAqueous humor
dc.subject.otherArticle
dc.subject.otherAutoclave
dc.subject.otherControlled study
dc.subject.otherDrug absorption
dc.subject.otherDrug bioavailability
dc.subject.otherDrug formulation
dc.subject.otherEye irritation
dc.subject.otherFemale
dc.subject.otherFlow kinetics
dc.subject.otherGel
dc.subject.otherIn vivo study
dc.subject.otherMale
dc.subject.otherNonhuman
dc.subject.otherPH
dc.subject.otherPriority journal
dc.subject.otherRabbit
dc.subject.otherShear flow
dc.subject.otherTransition temperature
dc.subject.otherAcrylic Resins
dc.subject.otherAdministration, Ophthalmic
dc.subject.otherAnimals
dc.subject.otherAnti-Inflammatory Agents, Non-Steroidal
dc.subject.otherAqueous Humor
dc.subject.otherDiclofenac
dc.subject.otherDrug Administration Routes
dc.subject.otherDrug Compounding
dc.subject.otherDrug Delivery Systems
dc.subject.otherExcipients
dc.subject.otherEye
dc.subject.otherGels
dc.subject.otherHot Temperature
dc.subject.otherMale
dc.subject.otherOphthalmic Solutions
dc.subject.otherPhase Transition
dc.subject.otherPhysicochemical Phenomena
dc.subject.otherPoloxamer
dc.subject.otherRabbits
dc.subject.otherSterilization
dc.subject.otherTransition Temperature
dc.titleOptimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-79955964137&doi=10.1016%2fj.ijpharm.2011.03.054&partnerID=40&md5=e6796a020ba5dd296f3ed09e332ccf9f

Files